Page 128 - Read Online

Melnik et al. J Transl Genet Genom 2022;6:1-45 https://dx.doi.org/10.20517/jtgg.2021.37 Page 31

205. Howell JJ, Ricoult SJ, Ben-Sahra I, Manning BD. A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans
2013;41:906-12. DOI PubMed
206. Ben-Sahra I, Manning BD. mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol 2017;45:72-82. DOI
PubMed PMC
207. Rabanal-Ruiz Y, Korolchuk VI. mTORC1 and nutrient homeostasis: the central role of the lysosome. Int J Mol Sci 2018;19:818.
DOI PubMed PMC
208. Tee AR. The target of rapamycin and mechanisms of cell growth. Int J Mol Sci 2018;19:880. DOI PubMed PMC
209. Condon KJ, Sabatini DM. Nutrient regulation of mTORC1 at a glance. J Cell Sci 2019;132:jcs222570. DOI PubMed PMC
210. Zhu M, Wang XQ. Regulation of mTORC1 by small GTPases in response to nutrients. J Nutr 2020;150:1004-11. DOI PubMed
211. Melick CH, Jewell JL. Regulation of mTORC1 by upstream stimuli. Genes (Basel) 2020;11:989. DOI PubMed PMC
212. Rich-Edwards JW, Ganmaa D, Pollak MN, et al. Milk consumption and the prepubertal somatotropic axis. Nutr J 2007;6:28. DOI
PubMed PMC
213. Barrea L, Di Somma C, Macchia PE, et al. Influence of nutrition on somatotropic axis: milk consumption in adult individuals with
moderate-severe obesity. Clin Nutr 2017;36:293-301. DOI PubMed
214. Grimberg A, Cohen P. Growth hormone and prostate cancer: guilty by association? J Endocrinol Invest 1999;22:64-73. PubMed
PMC
215. Weiss-Messer E, Merom O, Adi A, et al. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and
cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Mol Cell Endocrinol 2004;220:109-
23. DOI PubMed
216. Bidosee M, Karry R, Weiss-Messer E, Barkey RJ. Regulation of growth hormone receptors in human prostate cancer cell lines. Mol
Cell Endocrinol 2009;309:82-92. DOI PubMed
217. Bidosee M, Karry R, Weiss-Messer E, Barkey RJ. Growth hormone affects gene expression and proliferation in human prostate
cancer cells. Int J Androl 2011;34:124-37. DOI PubMed
218. Nakonechnaya AO, Shewchuk BM. Growth hormone enhances LNCaP prostate cancer cell motility. Endocr Res 2015;40:97-105.
DOI PubMed
219. Laron Z. Lessons from 50 years of study of Laron syndrome. Endocr Pract 2015;21:1395-402. DOI PubMed
220. Lin S, Li C, Li C, Zhang X. Growth hormone receptor mutations related to individual dwarfism. Int J Mol Sci 2018;19:1433. DOI
PubMed PMC
221. Shevah O, Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary
report. Growth Horm IGF Res 2007;17:54-7. DOI PubMed
222. Steuerman R, Shevah O, Laron Z. Congenital IGF1 deficiency tends to confer protection against post-natal development of
malignancies. Eur J Endocrinol 2011;164:485-9. DOI PubMed
223. Lapkina-Gendler L, Rotem I, Pasmanik-Chor M, et al. Identification of signaling pathways associated with cancer protection in Laron
syndrome. Endocr Relat Cancer 2016;23:399-410. DOI PubMed
224. Werner H, Sarfstein R, Nagaraj K, Laron Z. Laron syndrome research paves the way for new insights in oncological investigation.
Cells 2020;9:2446. DOI PubMed PMC
225. Wang Z, Prins GS, Coschigano KT, et al. Disruption of growth hormone signaling retards early stages of prostate carcinogenesis in
the C3(1)/T antigen mouse. Endocrinology 2005;146:5188-96. DOI PubMed
226. Wang Z, Luque RM, Kineman RD, et al. Disruption of growth hormone signaling retards prostate carcinogenesis in the Probasin/TAg
rat. Endocrinology 2008;149:1366-76. DOI PubMed PMC
227. Muñoz-Moreno L, Schally AV, Prieto JC, Carmena MJ, Bajo AM. Growth hormone-releasing hormone receptor antagonists modify
molecular machinery in the progression of prostate cancer. Prostate 2018;78:915-26. DOI PubMed
228. Recouvreux MV, Wu JB, Gao AC, et al. Androgen receptor regulation of local growth hormone in prostate cancer cells.
Endocrinology 2017;158:2255-68. DOI PubMed PMC
229. Rogers I, Emmett P, Gunnell D, Dunger D, Holly J; ALSPAC Study Tteam. Milk as a food for growth? Public Health Nutr
2006;9:359-68. DOI PubMed
230. Norat T, Dossus L, Rinaldi S, et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J
Clin Nutr 2007;61:91-8. DOI PubMed
231. Crowe FL, Key TJ, Allen NE, et al. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and
IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2009;18:1333-40.
DOI PubMed
232. Qin LQ, He K, Xu JY. Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food
Sci Nutr 2009;60 Suppl 7:330-40. DOI PubMed
233. Srinivasan V, Nimptsch K, Rohrmann S. Associations of current, childhood, and adolescent milk intake with serum insulin-like
growth factor (IGF)-1 and IGF binding protein 3 concentrations in adulthood. Nutr Cancer 2019;71:931-8. DOI PubMed
234. Romo Ventura E, Konigorski S, Rohrmann S, et al. Association of dietary intake of milk and dairy products with blood
concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults. Eur J Nutr 2020;59:1413-20. DOI PubMed
235. Watling CZ, Kelly RK, Tong TYN, et al. Associations of circulating insulin-like growth factor-I with intake of dietary proteins and
other macronutrients. Clin Nutr 2021;40:4685-93. DOI PubMed PMC
236. Hoppe C, Mølgaard C, Dalum C, Vaag A, Michaelsen KF. Differential effects of casein versus whey on fasting plasma levels of
insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys. Eur J Clin Nutr